Swedish company Egetis Therapeutics has raised around $16 million in a private share placement led by US healthcare investor Frazier Life Sciences. 11 October 2023
Danish biotech MinervaX, a privately held firm working on a novel, prophylactic vaccine against Group B Streptococcus (GBS), has raised $57 million from a range 11 October 2023
In the USA, the National Institutes of Health has outlined significant new investments to support research into amyotrophic lateral sclerosis (ALS). 10 October 2023
Swiss biotech LimmaTech Biologics has announced the closing of a $37 million Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Hold 9 October 2023
A privately-held drug discovery company based in San Diego, USA, has raised $100 million in a series B financing co-led by Ascenta Capital and Abingworth. 5 October 2023
The UK is in a strong position to become “a global leader in mRNA medicine,” according to a new report by industry cheerleader the BioIndustry Association (BIA) 4 October 2023
California-based Vistagen Therapeutics, a company aiming to transform the treatment landscape for anxiety, depression, and other central nervous system (CNS) di 4 October 2023
Madrigal Pharmaceuticals, a US biopharma pursuing new therapeutics for nonalcoholic steatohepatitis (NASH), has announced the pricing of its underwritten public 2 October 2023
A $250 million private financing for California’s BridgeBio Pharma will support a possible launch of acoramidis, as well as further late-stage pipeline developm 26 September 2023
Danish company Acesion Pharma has closed an oversubscribed series B financing round, raising around $48 million to support its work in atrial fibrillation (AF). 26 September 2023
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.